Ranucci Marco, Cazzaniga Anna, Soro Giorgio, Isgrò Giuseppe, Frigiola Alessandro, Menicanti Lorenzo
Departments of Cardiothoracic Anesthesia and Cardiac Surgery, Cardiovascular Center E. Malan-University of Milan, Istituto Policlinico S.Donato, Milan, Italy.
J Cardiothorac Vasc Anesth. 2002 Jun;16(3):316-20. doi: 10.1053/jcan.2002.124140.
To investigate the perioperative changes of antithrombin III (AT-III) activity using reduced systemic heparinization and the possible role of AT-III in determining a better postoperative outcome.
Prospective randomized study.
University hospital.
Patients undergoing elective coronary revascularization with cardiopulmonary bypass (n = 90).
Of patients, 30 were treated with heparin-coated circuits and reduced systemic heparinization; 30, with heparin-coated circuits and full systemic heparinization; 30, with conventional circuits and full systemic heparinization.
Heparin-coated circuits with full systemic heparinization did not exert any effect on coagulation parameters. Low systemic heparinization resulted in a significantly (p < 0.01) higher hematocrit value on arrival in the intensive care unit and in significantly higher values of AT-III activity during cardiopulmonary bypass (66 +/- 12% v 57.4 +/- 13% and 59.1 +/- 12% in the full systemic heparinization groups; p < 0.05), on arrival in the intensive care unit (69.7 +/- 13% v 60.7 +/- 13% and 60.8 +/- 11% in the full systemic heparinization groups; p < 0.01), and on the first postoperative day (81.3 +/- 15% v 67.4 +/- 13% and 70.2 +/- 12% in the full systemic heparinization groups; p < 0.01). No differences were observed in the clinical outcome.
Reducing systemic heparinization determines an AT-III-saving effect that could be responsible for the decrease in thromboembolic complications already observed by other authors. It induces higher hematocrit levels immediately after the operation, probably reducing the unmeasurable intraoperative blood loss.
探讨采用减少全身肝素化时抗凝血酶III(AT-III)活性的围手术期变化以及AT-III在确定更好术后结局中的可能作用。
前瞻性随机研究。
大学医院。
接受择期冠状动脉血运重建并使用体外循环的患者(n = 90)。
患者中,30例采用肝素涂层回路并减少全身肝素化治疗;30例采用肝素涂层回路并进行充分全身肝素化;30例采用传统回路并进行充分全身肝素化。
采用充分全身肝素化的肝素涂层回路对凝血参数无任何影响。低全身肝素化导致在重症监护病房入院时血细胞比容值显著更高(p < 0.01),并且在体外循环期间AT-III活性值显著更高(充分全身肝素化组分别为66 ± 12% 对57.4 ± 13%和59.1 ± 12%;p < 0.05),在重症监护病房入院时(充分全身肝素化组分别为69.7 ± 13% 对60.7 ± 13%和60.8 ± 11%;p < 0.01),以及在术后第一天(充分全身肝素化组分别为81.3 ± 15% 对67.4 ± 13%和70.2 ± 12%;p < 0.01)。临床结局未观察到差异。
减少全身肝素化可产生节省AT-III的效应,这可能是其他作者已观察到的血栓栓塞并发症减少的原因。它在术后立即诱导更高的血细胞比容水平,可能减少了术中不可测量的失血。